No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Diagnostics & Research
Mettler-Toledo International Inc. is a global leader in manufacturing and supplying high-precision instruments and comprehensive services. The company organizes its operations across five distinct geographical segments: the U.S., Switzerland, Western Europe, China, and Other regions. Its extensive product portfolio includes a wide array of laboratory instruments such as analytical balances, liquid handling solutions, automated laboratory reactors, titrators, pH meters, process analytics sensors, physical value analyzers, and thermal analysis systems, complemented by the LabX software platform for data management. For industrial use, they provide industrial weighing systems, automatic dimensional measurement and data capture tools, vehicle scales, specialized industrial software, and advanced product inspection technologies like metal detection, X-ray, checkweighing, camera-based imaging, and track-and-trace solutions. In the retail sector, Mettler-Toledo offers networked and standalone scales, along with automated packaging and labeling systems specifically designed for fresh goods. Their diverse customer base includes the life science industry, independent research and testing organizations, food and beverage manufacturers, food retailers, chemical and cosmetics companies, transportation and logistics, metals, electronics industries, and academia, all served through a combination of direct sales and indirect distribution channels. Founded in 1991, the company's headquarters are located in Columbus, Ohio.
www.mt.comNo one on the platform currently holds 0K10.L.
No tracked institution reports a position in 0K10.L as of their last filing.
No one on the platform has traded 0K10.L yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 41.1% | 44.3% | 39.9% | — | — | — |
| Rev. Growth % | 4.0% | 5.5% | ||||
| Profit Margin % | 21.6% | 21.5% | 19.2% | |||
| Free Cash Flow Margin % | 21.1% | 21.3% | 18.5% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $4.2B | +5.9% | $47.33 | $46.98–$47.79 | — | 1 |
| 2027 | $4.4B | +4.7% | $51.64 | $51.26–$52.15 | — | 1 |
| 2028 | $4.7B | +5.2% | $57.46 | $57.04–$58.03 | — | 1 |
| 2029 | $4.9B | +4.7% | $63.68 | $63.21–$64.30 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 8 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-07-30 | $10.85 | $11.46 | +5.6% |
| 2026-05-07 | $8.71 | $8.91 | +2.3% |
| 2026-02-05 | $12.80 | $13.36 | +4.4% |
| 2025-11-06 | $10.66 | $11.15 | +4.6% |
| 2025-07-31 | $9.60 | $9.76 | +1.7% |
| 2025-05-01 | $7.88 | $8.19 | +3.9% |
| 2025-02-06 | $11.72 | $11.96 | +2.0% |
| 2024-11-08 | $10.01 |
| $10.21 |
| +2.0% |
| +8.85% |
| $34.3B |
| — |
| 0J9P.LIncyte Corporation | $121.28 | -0.97% | $24.0B | — |
| 0JAV.LInsmed Incorporated | $119.19 | -5.05% | $25.8B | — |
Source: Financial Modeling Prep · peers by sector/industry